SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-052940
Filing Date
2023-10-11
Accepted
2023-10-11 17:03:31
Documents
14
Period of Report
2023-10-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20231008.htm   iXBRL 8-K 55008
2 EX-99.1 axsm-ex99_1.htm EX-99.1 16557
3 GRAPHIC img36028404_0.jpg GRAPHIC 22496
  Complete submission text file 0000950170-23-052940.txt   222767

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20231008.xsd EX-101.SCH 2451
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20231008_pre.xml EX-101.PRE 9441
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20231008_lab.xml EX-101.LAB 12806
8 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20231008_htm.xml XML 4543
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 231321261
SIC: 2834 Pharmaceutical Preparations